Antidiabetic activity of Anredera cordifolia (Ten.) Stennis extracts with different ethanol percentages: an evaluation based on in vitro, in vivo, and molecular studies
Creators
- 1. Research Center for Vaccine and Drugs Development, National Research and Innovation Agency (BRIN), South Tangerang, Indonesia
- 2. Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), South Tangerang, Indonesia
- 3. Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), South Tangerang, Indonesia|Universitas Sultan Ageng Tirtayasa, Serang, Indonesia
Description
Anredera cordifolia (Ten.) Stennis, also known as Binahong (B), is an Indonesian plant used to treat diabetes. The purpose of this study was to determine the best extragent for preparing Binahong extract as an antidiabetic agent using different concentrations of ethanol (50%, 70%, and 96%), labelled as BE50%, BE70%, and BE96%. An alpha-glucosidase inhibiting assay was used to assess the activity. The most active extract was tested in vivo assay using an oral glucose tolerance test (OGTT) and alloxan-high feed diet (alloxan-HFD)-induced diabetes in rats, with glucose level and beta cell Langerhans repair as parameters. A molecular assay was also performed to look into the expression of homeostasis regulator genes on 3T3-L1 adipose cells. The results showed that 96% ethanol extract (BE96%) inhibited alpha-glucosidase the most effectively (IC50 119.78± 11.14 μg/mL). The in vivo assay revealed that the treatment BE96% at 250 mg/kg BW for 21 consecutive days significantly reduced plasma glucose levels in Type 2 DM rats compared to the control group (p ≤ .05) with improved of Langerhans beta cells. BE96% also significantly reduced postprandial glucose levels. At the cellular level, Oil-Red-O staining revealed that differentiated adipocytes treated with BE96% had the highest lipid absorbance (p ≤ .05), compared to the control. BE96% significantly increased the expression of Glucose Transporter Isoform 4 (GLUT4) at the molecular level. It could be concluded that BE96% exhibited the best antidiabetic properties.
Files
PHAR_article_94899.pdf
Files
(795.2 kB)
Name | Size | Download all |
---|---|---|
md5:b8133b8b3e1dc930ce80c8d38b006b0d
|
689.0 kB | Preview Download |
md5:abce2a3a96c38493f0dfed6362d48738
|
106.2 kB | Preview Download |
Additional details
Related works
- Has part
- Figure: 10.3897/pharmacia.70.e94899.figure3 (DOI)
- Figure: 10.3897/pharmacia.70.e94899.figure4 (DOI)
- Figure: 10.3897/pharmacia.70.e94899.figure1 (DOI)
- Figure: 10.3897/pharmacia.70.e94899.figure2 (DOI)